BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10770789)

  • 1. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
    Domaracki BE; Evans AM; Venezia RA
    Antimicrob Agents Chemother; 2000 May; 44(5):1394-6. PubMed ID: 10770789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
    Ferrara A; Dos Santos C; Cimbro M; Gialdroni Grassi G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):535-7. PubMed ID: 9272391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
    Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
    Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
    Climo MW; Patron RL; Archer GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
    Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus.
    Lu X; Yang X; Li X; Lu Y; Ren Z; Zhao L; Hu X; Jiang J; You X
    PLoS One; 2013; 8(7):e68053. PubMed ID: 23844154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
    Raymond J; Vedel G; Bergeret M
    J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.
    Komatsuzawa H; Suzuki J; Sugai M; Miyake Y; Suginaka H
    J Antimicrob Chemother; 1994 Jun; 33(6):1155-63. PubMed ID: 7928809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
    Rochon-Edouard S; Pestel-Caron M; Lemeland JF; Caron F
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3055-60. PubMed ID: 11036022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
    Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
    Joukhadar C; Pillai S; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2010 Feb; 54(2):773-7. PubMed ID: 19933805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model.
    Allen GP; Cha R; Rybak MJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2606-12. PubMed ID: 12121940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis.
    Brilene T; Soeorg H; Kiis M; Sepp E; Kõljalg S; Lõivukene K; Jürna-Ellam M; Kalinina J; Stšepetova J; Metsvaht T; Lutsar I
    APMIS; 2013 Sep; 121(9):859-64. PubMed ID: 23294372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.